ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions

Core Viewpoint - ONWARD Medical N.V. is set to hold its 2026 Annual General Meeting (AGM) on May 13, 2026, in Amsterdam, focusing on key resolutions and company developments in neurotechnology for spinal cord injuries and movement disabilities [1][2]. Company Overview - ONWARD Medical is a leading neurotechnology company that develops therapies aimed at restoring movement, function, and independence for individuals with spinal cord injuries (SCI) and other movement disabilities [3]. - The company has developed ARC Therapy, which has received 10 Breakthrough Device Designations from the FDA, and its ARC-EX System is commercially available in the US and Europe [3]. - An investigational implantable system, ARC-IM, is under development to address unmet needs such as blood pressure instability post-spinal cord injury and can integrate with brain-computer interfaces (BCI) and artificial intelligence (AI) for thought-driven movement restoration [3]. AGM Resolutions - The AGM will discuss the annual report and accounts for the financial year 2025, including the implementation of the compensation policy and the dividend and reservation policy [4]. - Key voting items include the release of directors from liability for their duties during the financial year 2025, the appointment and re-appointment of non-executive directors, and the delegation of authority to issue ordinary shares and acquire shares [4].